The rationale for our trial relies on the fact that TNAP activity is higher and PPi is lower in PXE patients compared with non-PXE subjects [3,4], and that TNAP activity could be partially inhibited by lansoprazole [14]. Here, ALPL is linked to pseudoxanthoma elasticum (inherited or acquired).